002365.SZ

Qianjiang Yongan Pharmaceutical Co., Ltd. [002365.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002365.SZ Stock Summary

Top 10 Correlated ETFs

002365.SZ


Top 10 Correlated Stocks

002365.SZ


In the News

002365.SZ Financial details

Company Rating
Neutral
Market Cap
2.2B
Income
24.36M
Revenue
1.14B
Book val./share
7.27
Cash/share
3.27
Dividend
0.1
Dividend %
1.03%
Employees
1K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2021
P/E
118.84
Forward P/E
-
PEG
-15.15
P/S
2.52
P/B
1.42
P/C
2.25
P/FCF
-1035.89
Quick Ratio
4.29
Current Ratio
4.6
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
26.32%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.99%
Revenue last 5Y
7.78%
Revenue Q/Q
-16.05%
EPS Q/Q
-124.64%
-
-
-
-
SMA20
-
SMA50
-30%
SMA100
-30%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.02%
Gross Margin
34%
Oper. Margin
4%
Profit Margin
2%
Payout
158%
Shs Outstand
294.68M
Shs Float
266.83M
-
-
-
-
Target Price
-
52W Range
5.45-11.83
52W High
-33.09%
52W Low
+47.2%
RSI
48
Rel Volume
0.87
Avg Volume
4.57M
Volume
3.97M
Perf Week
-2.26%
Perf Month
30.04%
Perf Quarter
-
Perf Half Y
-27.06%
-
-
-
-
Beta
0.24
-
-
Volatility
0.16%, 0.33%
Prev Close
2.08%
Price
7.36
Change
1.66%

002365.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.474.744.075.464.97
Net income per share
0.620.310.370.390.48
Operating cash flow per share
1.080.830.720.361.32
Free cash flow per share
0.150.360.350.140.81
Cash per share
0.21.742.591.912.83
Book value per share
5.465.586.096.516.85
Tangible book value per share
5.215.395.956.496.83
Share holders equity per share
5.465.586.096.516.85
Interest debt per share
0.010.010.430.080.14
Market cap
2.92B2.85B2.71B3.04B3.09B
Enterprise value
2.9B2.74B2.71B2.97B2.86B
P/E ratio
16.3431.7125.6327.322.02
Price to sales ratio
2.92.082.311.942.11
POCF ratio
9.2911.9113.0929.887.98
PFCF ratio
65.5527.1226.4678.4712.97
P/B Ratio
1.851.771.541.631.53
PTB ratio
1.851.771.541.631.53
EV to sales
2.8822.311.91.95
Enterprise value over EBITDA
9.8311.0510.2611.258.94
EV to operating cash flow
9.2311.4313.1329.167.37
EV to free cash flow
65.0826.0426.5476.5911.99
Earnings yield
0.060.030.040.040.05
Free cash flow yield
0.020.040.040.010.08
Debt to equity
000.070.010.02
Debt to assets
000.060.010.02
Net debt to EBITDA
-0.07-0.460.03-0.28-0.73
Current ratio
2.793.643.313.634.19
Interest coverage
29.28K408.95111.453.93229.38
Income quality
1.762.241.740.862.92
Dividend Yield
0.010.010.020.010
Payout ratio
0.110.330.430.280.01
Sales general and administrative to revenue
0.010.020.020.020.06
Research and developement to revenue
0.020.040.040.030.03
Intangibles to total assets
0.050.050.050.040.04
Capex to operating cash flow
-0.86-0.56-0.51-0.62-0.38
Capex to revenue
-0.27-0.1-0.09-0.04-0.1
Capex to depreciation
-3.38-1.19-0.92-0.54-1.21
Stock based compensation to revenue
0000.010
Graham number
8.76.257.087.548.58
ROIC
0.110.070.060.060.06
Return on tangible assets
0.10.050.050.050.06
Graham Net
-0.331.432.031.982.51
Working capital
492.18M549.14M717.31M772.52M910.22M
Tangible asset value
1.51B1.56B1.72B1.86B2.01B
Net current asset value
443.82M505.9M677.62M736.94M874.17M
Invested capital
000.070.010.02
Average receivables
169.88M155.87M172.86M282.34M285.46M
Average payables
95.15M126.76M104.37M106.24M138.84M
Average inventory
88.93M100.74M92.9M113.72M147.69M
Days sales outstanding
59.1439.6461.2785.7650.69
Days payables outstanding
79.2938.5843.6234.7560.58
Days of inventory on hand
54.2236.1436.5144.0955.67
Receivables turnover
6.179.215.964.267.2
Payables turnover
4.69.468.3710.56.03
Inventory turnover
6.7310.1108.286.56
ROE
0.110.060.060.060.07
Capex per share
-0.93-0.46-0.36-0.22-0.51

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.991.141.060.910.8
Net income per share
0.15-0.070.050.14-0.03
Operating cash flow per share
0.15-0.070.050.380.13
Free cash flow per share
0-0.3-0.070.310.06
Cash per share
2.512.82.83.113.27
Book value per share
6.826.796.96.977.27
Tangible book value per share
6.796.766.876.957.22
Share holders equity per share
6.826.796.96.977.27
Interest debt per share
0.030.130.030.030.04
Market cap
3.11B3.12B3.24B2.87B2.88B
Enterprise value
3.01B2.89B3.04B2.61B2.61B
P/E ratio
17.27-35.3554.0417.42-74.13
Price to sales ratio
10.519.210.4110.7312.82
POCF ratio
69.09-141.4216.1525.981.53
PFCF ratio
-7.93K-34.58-161.9231.17186.05
P/B Ratio
1.531.551.591.41.41
PTB ratio
1.531.551.591.41.41
EV to sales
10.188.59.789.7711.63
Enterprise value over EBITDA
65.25170.38622.0756.88420.96
EV to operating cash flow
66.9-130.77203.1523.5873.99
EV to free cash flow
-7.68K-31.98-152.1828.37168.84
Earnings yield
0.01-0.0100.010
Free cash flow yield
0-0.03-0.010.030.01
Debt to equity
00.02000
Debt to assets
00.02000
Net debt to EBITDA
-2.14-13.86-39.8-5.61-42.9
Current ratio
5.664.194.344.314.6
Interest coverage
1.19K-358.36179.38886.215.26
Income quality
1112.69-3.64
Dividend Yield
00000.01
Payout ratio
0-0.050.010-3.82
Sales general and administrative to revenue
0.170.060.11-0.070.43
Research and developement to revenue
0.040.020.030.050.06
Intangibles to total assets
0.040.040.040.040.04
Capex to operating cash flow
-1.013.09-2.33-0.17-0.56
Capex to revenue
-0.15-0.2-0.11-0.07-0.09
Capex to depreciation
-1.44-2.16-1.04-0.550.29
Stock based compensation to revenue
00000
Graham number
4.813.372.814.682.38
ROIC
0.02-0.010.010.020
Return on tangible assets
0.02-0.010.010.020
Graham Net
2.652.482.562.722.89
Working capital
975.71M910.22M928.68M931.44M948.16M
Tangible asset value
2.03B2.01B2.03B2.05B2.03B
Net current asset value
944.89M874.17M892.91M897.9M904.8M
Invested capital
00.02000
Average receivables
309.17M233.35M211.27M217.58M212.41M
Average payables
103.8M126.23M179.59M168.77M147.33M
Average inventory
169.26M160.58M153.18M119.11M81.72M
Days sales outstanding
80.0853.8763.4772.6583.86
Days payables outstanding
41.8276.2280.1374.2483.41
Days of inventory on hand
80.0170.0563.9542.8544.53
Receivables turnover
1.121.671.421.241.07
Payables turnover
2.151.181.121.211.08
Inventory turnover
1.121.281.412.12.02
ROE
0.02-0.010.010.020
Capex per share
-0.15-0.23-0.12-0.06-0.07

002365.SZ Frequently Asked Questions

What is Qianjiang Yongan Pharmaceutical Co., Ltd. stock symbol ?

Qianjiang Yongan Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 002365.SZ

What is Qianjiang Yongan Pharmaceutical Co., Ltd. stock quote today ?

Qianjiang Yongan Pharmaceutical Co., Ltd. stock price is $7.36 today.

Is Qianjiang Yongan Pharmaceutical Co., Ltd. stock public?

Yes, Qianjiang Yongan Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap